- Home
- / Foundation Medicine
Foundation Medicine
Revenue
$152.9 M
FY, 2017
Foundation Medicine Summary
Company Summary
- Overview
- Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies. It offers comprehensive genomic profiling (CGP), immunohistochemistry (IHC), and germline testing. The company also provides biomarker discovery, translational research, and clinical trial design services.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2010
- HQ
- Boston, MA, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Winifred Lynn Swan, General Counsel and Chief Legal Officer
Andrew Suchoff, Chief People Officer
Kathleen Kaa, Chief Commercial Officer a.i.. Vice President, Commercial Programs
Operating MetricsView all
Patients Tested to Date
500K
25.0%
Jul, 2022
Biopharma Partners
65
30.0%
Jul, 2022
Peer-Reviewed Publications
500
Jul, 2022
LocationsView all
4 locations detected
Boston, MA HQ
United States
400 Summer St
Morrisville, NC
United States
7010 Kit Creek Rd
San Diego, CA
United States
11010 Torreyana Rd
Penzberg, BY
Germany
Nonnenwald 2/building 433 d
Foundation Medicine Financials
Summary Financials
- Revenue (Q2, 2018)
- $38.7M
- Gross profit (Q2, 2018)
- $11.2M
- Net income (Q2, 2018)
- ($33.4M)
- Cash (Q2, 2018)
- $53.4M
- EBIT (Q2, 2018)
- ($32.1M)